ARCHIVES

DT Board Oks RFAs In Surgery, HIV, Breast Cancer

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

In Brief: House, Senate Differ On NCI Positions; Upton Says Viral Oncology research Will Be Continued

August 12, 1977

Movement To Resolve Patient Care Reimbursement Problems Gains Momentum; NCI Report Adds Fuel

March 17, 1989